Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
| Amgen To Present At The Barclays Biosimilars Symposium | ||
| By: PR Newswire Association LLC. - 02 Oct 2015 | Back to overview list |
|
THOUSAND OAKS, Calif., Oct. 2, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Barclays Biosimilars Symposium at 8 a.m. ET on Wednesday, Oct. 7, 2015, in New York City. Scott Foraker, vice president and general manager of Biosimilars at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for at least 90 days following the event. About Amgen Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen. CONTACT: Amgen, Thousand Oaks Logo - http://photos.prnewswire.com/prnh/20081015/AMGENLOGO
SOURCE Amgen 
|
||
|
||
 | Back to overview list | |